open access

Vol 72, No 3 (2021)
Clinical vignette
Published online: 2021-06-30
Submitted: 2021-04-14
Accepted: 2021-04-18
Get Citation

Increased efficacy of hypothyroidism control with liquid levothyroxine [Większa skuteczność lewotyroksyny w postaci płynnej w wyrównywaniu niedoczynności tarczycy]

Marek Ruchała
DOI: 10.5603/EP.a2021.0049
·
Pubmed: 34292578
·
Endokrynologia Polska 2021;72(3):271-275.

open access

Vol 72, No 3 (2021)
Clinical Vignette
Published online: 2021-06-30
Submitted: 2021-04-14
Accepted: 2021-04-18

Abstract

Not required for Clinical Vignette.

Abstract

Not required for Clinical Vignette.

Get Citation

Keywords

hypothyroidism; liquid levothyroxine; Tirosint SOL

About this article
Title

Increased efficacy of hypothyroidism control with liquid levothyroxine [Większa skuteczność lewotyroksyny w postaci płynnej w wyrównywaniu niedoczynności tarczycy]

Journal

Endokrynologia Polska

Issue

Vol 72, No 3 (2021)

Article type

Clinical vignette

Pages

271-275

Published online

2021-06-30

DOI

10.5603/EP.a2021.0049

Pubmed

34292578

Bibliographic record

Endokrynologia Polska 2021;72(3):271-275.

Keywords

hypothyroidism
liquid levothyroxine
Tirosint SOL

Authors

Marek Ruchała

References (5)
  1. Okosieme OE, Belludi G, Spittle K, et al. Adequacy of thyroid hormone replacement in a general population. QJM. 2011; 104(5): 395–401.
  2. Ruchała M, Szczepanek-Parulska E, Zybek A. The influence of lactose intolerance and other gastro-intestinal tract disorders on L-thyroxine absorption. Endokrynol Pol. 2012; 63(4): 318–323.
  3. Yue CS, Scarsi C, Ducharme MP. Pharmacokinetics and potential advantages of a new oral solution of levothyroxine vs. other available dosage forms. Arzneimittelforschung. 2012; 62(12): 631–636.
  4. Fallahi P, Ferrari SM, Antonelli A. Oral L-thyroxine liquid versus tablet in patients with hypothyroidism without malabsorption: a prospective study. Endocrine. 2016; 52(3): 597–601.
  5. Gietka-Czernel M, Hubalewska-Dydejczyk A, Kos-Kudła B, et al. Expert opinion on liquid L-thyroxine usage in hypothyroid patients and new liquid thyroxine formulation - Tirosint SOL [Opinia ekspertów dotycząca stosowania płynnej postaci lewotyroksyny oraz nowego preparatu Tirosint SOL u chorych na niedoczynność tarczycy]. Endokrynol Pol. 2020; 71(5): 441–465.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Via MedicaWydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl